Neurological safety of fingolimod: An updated review

about

Long-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis.Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod.

P2860

Q49164654-7BE9111A-E1A4-41F4-93F7-326FA494899A Q55715593-ED3FE6FF-9D73-4DD8-AB84-73CECD5FAC59

P2860

Neurological safety of fingolimod: An updated review

Item

http://www.wikidata.org/entity/Q41553443

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Neurological safety of fingolimod: An updated review

@en

type

Item

label

Neurological safety of fingolimod: An updated review

@en

prefLabel

Neurological safety of fingolimod: An updated review

@en

P1476

Neurological safety of fingolimod: An updated review

@en

P2093

Fumihito Yoshii

http://www.w3.org/2001/XMLSchema#string

Masafuchi Ryo

http://www.w3.org/2001/XMLSchema#string

Tomohide Ohnuki

http://www.w3.org/2001/XMLSchema#string

Wakoh Takahashi

http://www.w3.org/2001/XMLSchema#string

Yusuke Moriya

http://www.w3.org/2001/XMLSchema#string

P2860

Fingolimod for relapsing-remitting multiple sclerosis

Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence

Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment

Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Classifying PML risk with disease modifying therapies.

P304

233-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN3.12397

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28932291

http://www.w3.org/2001/XMLSchema#string

P932

5575715

http://www.w3.org/2001/XMLSchema#string

Neurological safety of fingolimod: An updated review

about

P2860

P2860

Neurological safety of fingolimod: An updated review

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932